🇺🇸 Vincristina in United States
328 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 328
Most-reported reactions
- Febrile Neutropenia — 67 reports (20.43%)
- Neutropenia — 47 reports (14.33%)
- Thrombocytopenia — 38 reports (11.59%)
- Pancytopenia — 37 reports (11.28%)
- Pyrexia — 29 reports (8.84%)
- Leukopenia — 28 reports (8.54%)
- Anaemia — 26 reports (7.93%)
- Drug Interaction — 22 reports (6.71%)
- Asthenia — 17 reports (5.18%)
- Stomatitis — 17 reports (5.18%)
Other Other approved in United States
Frequently asked questions
Is Vincristina approved in United States?
Vincristina does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Vincristina in United States?
Fondazione Italiana Linfomi - ETS is the originator. The local marketing authorisation holder may differ — check the official source linked above.